Tailoring a Patient-Centered Approach: Treatment Options for Episodic Migraine

Please Log In or Register to continue.

Release Date: July 31, 2015
Expiration Date: July 31, 2016

Expected time to complete this activity as designed: 60 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

Migraine is a very common disorder, and in 2010 it was ranked by the World Health Organization as the 7th highest specific cause of disability globally and the leading cause of disability among neurological disorders. In the United States, the economic burden of migraine is estimated to be $30 billion annually. Migraine can be quite disabling, characterized by attacks of moderate-to-severe headache, and often accompanied by neurological, autonomic symptoms, and gastrointestinal symptoms including nausea, vomiting, and gastroparesis. Migraine episodes vary in frequency, intensity, and symptomatology, but, overall, 49.5% of patients report migraine-related nausea with at least half of their attacks. There is no cure for migraine. Treatments are aimed at reducing headache frequency and stopping individual headaches when they occur.

This activity will focus on optimizing treatment of acute episodic migraine based on guideline recommendations, including the need for proper assessment, ongoing patient communication regarding an optimal management plan, and a thorough knowledge of new and existing therapeutic options including oral and non-oral therapies.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, nurses, and other relevant multidisciplinary clinicians who provide care to patients with migraine.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Recognize impact of untreated or suboptimal treatment of migraine on quality of life for headache patients
  • Develop an individualized treatment plan focusing on a patient-centered approach which identifies potential barriers to treatment and optimizes outcomes
  • Compare and contrast potential side effects of therapeutic strategies, and develop a treatment which minimizes negative impact on continuation of therapy and patient compliance


Tailoring a Patient-Centered Approach: Treatment Options for Episodic Migraine – Stephanie J. Nahas, MD, FAHS, FAAN

Bonus Material: A Look at Preventive Treatment

Instructions for Participation and Credit

This activity is eligible for credit through July 31, 2016. After this date, this activity will expire and no further credit will be awarded.
1. Read the target audience, learning objectives, and faculty disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates for CME and CNE may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Stephanie J. Nahas, MD, FAHS, FAAN
Assistant Professor of Neurology
Thomas Jefferson University
Philadelphia, Pennsylvania

Dr. Stephanie Nahas received her medical degree from Rush Medical College in Chicago. She completed an internship in medicine at Rush Presbyterian St. Luke’s Medical Center, Chicago, as well as a residency in neurology and fellowship in headache medicine at Thomas Jefferson University Hospital, Philadelphia. Dr. Nahas is assistant professor of neurology at Thomas Jefferson University where she is also program director, headache medicine fellowship, Jefferson Headache Center, and assistant program director of neurology residency.

Dr. Nahas holds specialty certification in headache medicine from the United Council for Neurologic Subspecialties and in neurology from the American Board of Psychiatry and Neurology. In addition, she holds memberships in the International Headache Society, Pennsylvania Neurological Society, American Headache Society, and the American Academy of Neurology. Dr. Nahas is a reviewer for numerous publications including UpToDate, Frontiers in Neurology, BMC Neurology, PLOS One, Neurology, Acta Neurologica Scandinavica, Headache, and Cephalalgia.


Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-15-039-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.

Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour. Program Number: 15-039-010


As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Stephanie Nahas has disclosed no relevant financial relationships.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Nahas has indicated that she does intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Nahas has indicated that she does not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flashreg; Player, Adobe® Acrobat®, Windows Media® Player and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at info@emergingsolutionsinpain.com.

Provided by MediCom Worldwide, Inc.

This activity is supported by an unrestricted educational grant from Teva Pharmaceuticals.

©2015 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

Please Log In or Register to continue.